Page results
-
This information explains brain stem death and the tests used to confirm the diagnosis. It aims to answer frequently asked questions.
-
A healthcare project aimed at homeless people and delivered by UCLH has been specially commended in this year’s London Homelessness Awards.
-
Sarah, Duchess of York, and Their Royal Highnesses Princess Beatrice and Princess Eugenie met with staff and young people in a video call to formally open the specialist haematology ward for young adults in the University College Hospital Grafton Way Building last week (Monday 11 July).
-
Our mass vaccination centre at Bidborough House, which we have operated in partnership with UCL, closes on Friday 22 July.
-
Contrast Extravasation (contrast leakage) patient information leaflet
-
We are pleased to have performed very well again in this year's General Medical Council National Training Survey.
-
Art and creativity can be a real tonic for health, says UCLH arts curator Guy Noble.
-
Arif Ahmed is an entrepreneur and private equity investor in healthcare, technology, e-commerce and B2B services companies. He has a proven track record of scaling innovation in complex regulatory environments.
-
This page explains what you can expect after you have been referred to the Lymphoedema Service at University College London Hospitals (UCLH) for a video or telephone appointment.
-
UCLH has opened a new vaccine research centre with two clinical trials testing a long-acting antibody combination treatment to protect against Covid-19.
File results
-
FOI/2023/0187 - Treatment for urothelial and colorectal cancer
-
FOI/2023/0182 - Data privacy compliance tools
-
FOI/2023/0180 - Treatment guidelines for chronic kidney disease/ diabetic kidney disease
-
FOI/2023/0139 - Meningitis and Encephalitis guidelines/ pathway
-
FOI/2023/0145 - Waiting times for consultant-led treatment, inpatient and outpatients
-
FOI/2023/0143 - Immunoassay Analysers at Trust
-
FOI/2023/0142 - Treatment of breast cancer
-
FOI/2023/0152 - Wheelchair associated services
-
FOI/2023/0138 - Subject Access Requests (SARs) and Freedom of Information Requests
-
FOI/2023/0132 - Renal cell carcinoma and melanoma treatment